Study on the Effect of Inulin in Infant Formula on Gut Health

Inclusion criteria at screening: * Healthy infants between 3-4 months (91-120 days after birth) of age at day 1 of the study, with healthy growth determined based on WHO standard * Fully formula-fed in the 28 days prior to inclusion * Expected investigational product intake of min 500ml per day * Written informed consent from the parents Exclusion criteria at screening: * Low birth weight (LBW) less than 2,000g. * Disorders requiring a special diet (such as food intolerance or food allergy or complaints such as reflux, constipation and cramps for which special toddler formula is required) * Use of systemic antibiotics or antimycotics medication in the 14 days prior to the study * Significant congenital abnormality that will interfere with the study objectives in the opinion of the investigator. * Investigator's uncertainty about the willingness or ability of the parents to comply with the protocol requirements. * Participation in any other studies involving investigational or marketed products concomitantly or within two weeks prior to entry into the study. Exclusion criteria for intervention period: * Not consuming study product longer than 2 days consecutively * Intake of study product is less than 500ml per day for 7 days